SSI is a common complication
Individuals contract 500,000 to 780,000 surgical site infections (SSIs) in the United States annually.1,2 SSIs are one of the most common complications that a surgeon encounters, with an infection occurring after one of 780,000 operations in the United States annually.2
SSI-related costs
ChloraPrep reduces microorganisms that can cause SSIs
ChloraPrep, a combination of 2% chlorhexidine gluconate (CHG) and 70% isopropyl alcohol (IPA), helps improve clinical patient outcomes by reducing the skin-dwelling microorganisms that can cause SSIs. The applicator eliminates hand-to-patient contact, helping prevent cross contamination. Together, the formulation and applicator provide a proven system that supports infection control guidelines for reducing incidences of SSIs.
ChloraPrep advantages
Clinical studies support use of ChloraPrep and CHG formulations
According to a clinical study comparing ChloraPrep with two surgical preparation solutions — DuraPrep™ and Techni-Care® — ChloraPrep was the most efficacious for eliminating bacteria from hallux and toe sites (P<0.0001)9
Review other clinical studies and evidence-based guidelines supporting use of ChloraPrep and chlorhexidine-based formulations for patient preoperative skin preparation.
DuraPrep is a trademark of 3M Health Care; Techni-Care is a registered trademark of Care-Tech Laboratories, Inc.
1. Martone WJ, Nichols RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis. 33 Suppl 2 2001:S67-68.
2. Fletcher N, Sofianos D, Berkes MB, Obremskey WT. Prevention of perioperative infection. J Bone Joint Surg Am. 89 2007:1605-1618.
3. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of healthcare-associated infections. Am J Infect Control. 33 2005:501-509.
4 Garcia R, Mulberry G, Brady A, Hibbard JS. Comparison of ChloraPrep and Betadine as preoperative skin preparation antiseptics. Poster presented at: 40th Annual Meeting of the Infectious Disease Society of America; October 25, 2002.
5 Crosby CT , Mares AK. Skin antisepsis: past, present, and future. J Vasc Access Devices. Spring 2001:26-31.
6 Denton GW. Chlorhexidine. In: Block SS. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:321-336.
7 Data on file; Enturia.
8 Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med.2002;136:792-801.
9 Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87:980-985.
10 Gottardi W. Iodine and Iodine Compounds. In: Block SS. Disinfection, Serilization, and Preservation. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:159-183.
Call with questions.
Monday – Thursday
7 a.m. to 5 p.m. CST
Friday
7 a.m. to 1 p.m. CST
Information contained on this site pertains only to the United States of America.